Jump to main content
Jump to site search


Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis on Alzheimer's disease using UPLC-Q-TOF-MS

Abstract

Schisandra chinensis (Turcz.) Baill (S. chinensis), a functional food, is used as a tonic and sedative agent in traditional Chinese medicine. Modern pharmacological research has proven that S. chinensis could prevent and treat age-related neurodegenerative diseases. The presence of bioactive lignans in S. chinensis is the main reason for its neuroprotective and cognitive enhancement effects. This study aimed to clarify the mechanism of lignans in S. chinensis to ameliorate learning and memory deficits in Alzheimer's disease (AD) animals. Step-down test and Morris water maze (MWM) test were used to verify the effects of lignans in S. chinensis on learning and memory in AD animals. Then, metabolomics approaches based on ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) were used to clarify the mechanism of lignans in S. chinensis in treating AD. Finally, quantitative analysis of AD-related neurotransmitters in the brain was conducted after treatment with lignans in S. chinensis. In MWM and step-down test, lignans in S. chinensis had a clear ability to ameliorate the impaired learning and memory of AD animals. A total of 31 endogenous metabolites were identified after treatment with lignans in S. chinensis which were associated with lignans ameliorating learning and memory. These biomarkers were mainly associated with polyunsaturated fatty acid metabolism and amino acid and vitamin metabolism. Moreover, lignans in S. chinensis upregulated the levels of γ-aminobutyric acid (GABA), 5-hydroxytryptamine (5-HT), acetylcholine (Ach), norepinephrine (NE) and glycine (Gly), and downregulate the level of aspartic acid (Asp). Lignans in S. chinensis might alleviate the neurotoxic effects of neurological inflammation and oxidative stress, Aβ deposition, and tau phosphorylation via the regulation of multiple endogenous metabolic pathways during pathological AD. The research might provide useful support for the further study of pharmacology and new drug development of lignans in S. chinensis.

Back to tab navigation

Supplementary files

Publication details

The article was received on 02 Apr 2019, accepted on 26 Jul 2019 and first published on 06 Aug 2019


Article type: Paper
DOI: 10.1039/C9FO00677J
Food Funct., 2019, Accepted Manuscript

  •   Request permissions

    Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis on Alzheimer's disease using UPLC-Q-TOF-MS

    M. Wei, Z. Liu, Y. Liu, S. Li, M. Hu, K. Yue, T. Liu, Y. He, Z. Pi, Z. Liu and F. Song, Food Funct., 2019, Accepted Manuscript , DOI: 10.1039/C9FO00677J

Search articles by author

Spotlight

Advertisements